Company intelligence / Profile preview

Stanley Brothers

Ownership: Private
Development stage: Other

Overview

Stanley Brothers is a pioneer in the U.S. hemp and cannabis industry with vertically integrated operations including proprietary plant genetics, cultivation, extraction, and manufacturing. The company produces cannabinoid-based wellness products sold nationwide and has cGMP-certified facilities for active pharmaceutical ingredient production. Their brands include both CBD-dominant and low-dose THC formulations. They are known for their role in developing Charlotte’s Web CBD oil.

Therapeutic areas: PsychiatryNeurologyOther
Modalities: Small moleculeBotanical extractActive pharmaceutical ingredient
Industry: Biotech

Beyond the preview

Go deeper on Stanley Brothers.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Stanley Brothers.

Explore the full profile